Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Privium Fund Management B.V.
Form 13F · Q2 2026

Privium Fund Management B.V.

CIK 1795097Filed 2026-08-0713F-HR View the filing on EDGAR ↗
$544M
Reported book value
61
Positions
12
Quarters on record
Top 50
Positions

Privium Fund Management B.V. — holdings

Top 50 positions of 61, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1TSLA Tesla Inc228,000+2.7%$96M17.6%
2SHOP Shopify Inc370,000−9.1%$42M7.8%
3AMD Advanced Micro Devices Inc62,000+0.0%$36M6.6%
4AMZN Amazon Com Inc140,000+12.0%$33M6.1%
5IONS Ionis Pharmaceuticals Inc319,924+10.3%$25M4.7%
6SPOT Spotify Technology S A55,000−17.9%$25M4.6%
7PLTR Palantir Technologies Inc200,000+0.0%$23M4.3%
8ARWR Arrowhead Pharmaceuticals In234,222−36.2%$19M3.5%
9OPEN Opendoor Technologies Inc3.9M—$18M3.3%
10LMND Lemonade Inc270,259+5.9%$18M3.2%
11NVDA Nvidia Corporation81,000+0.0%$16M3.0%
12IREN Iren Limited340,150+6.2%$16M2.9%
13UNIQURE NV Uniqure Nv328,322−32.5%$15M2.8%
14CBRS Cerebras Systems Inc60,500—$13M2.5%
15ASTS Ast Spacemobile Inc145,000+0.0%$13M2.4%
16RARE Ultragenyx Pharmaceutical In338,800−7.1%$11M2.1%
17ARQT Arcutis Biotherapeutics Inc399,367+24.4%$10M1.9%
18BIIB Biogen Inc48,400+10.5%$10M1.9%
19PROQR THRAPEUTICS N V Proqr Thrapeutics N V5.5M+1.0%$10M1.9%
20AXSM Axsome Therapeutics Inc.39,944−32.0%$10M1.8%
21URGN Urogen Pharma Ltd210,000−11.8%$8M1.4%
22SPCX Space Exploration Techn Corp40,000—$7M1.3%
23DNLI Denali Therapeutics Inc229,857−9.8%$6M1.1%
24VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc9,400−17.2%$5M0.9%
25BMRN Biomarin Pharmaceutical Inc75,000−18.7%$4M0.8%
26KRYS Krystal Biotech Inc11,170+0.0%$4M0.8%
27ALNY Alnylam Pharmaceuticals Inc11,372−7.0%$3M0.6%
28VRDN Viridian Therapeutics Inc173,516+0.0%$3M0.6%
29BNTX Biontech Se30,100+11.5%$3M0.5%
30HIMS Hims & Hers Health Inc80,000+100.0%$3M0.5%
31MGTX Meiragtx Hldgs Plc196,112−7.5%$3M0.5%
32AMBEV SA Ambev Sa802,167−15.4%$3M0.5%
33SRPT Sarepta Therapeutics Inc136,500+196.7%$2M0.5%
34CRSP Crispr Therapeutics Ag44,974+4.9%$2M0.5%
35BEAM Beam Therapeutics Inc70,282+9.8%$2M0.4%
36ZLAB Zai Lab Ltd122,189−7.6%$2M0.4%
37MRNA Moderna Inc29,994+0.0%$2M0.4%
38RNAC Cartesian Therapeutics Inc151,675−15.3%$2M0.3%
39MICC Magnum Ice Cream Co Nv98,221—$1M0.3%
40WVE Wave Life Sciences Ltd241,010+0.0%$1M0.3%
41TSHA Taysha Gene Therapies Inc198,900+9.3%$1M0.2%
42ZTS Zoetis Inc17,322—$1M0.2%
43FDMT 4D Molecular Therapeutics In90,110−47.1%$1M0.2%
44FATE Fate Therapeutics Inc414,311+0.0%$1M0.2%
45LEGN Legend Biotech Corp35,400—$1M0.2%
46RCKT Rocket Pharmaceuticals Inc244,146+0.8%$834,9790.2%
47NOV Nov Inc42,026+0.0%$779,5820.1%
48BTG B2Gold Corp195,083+102.2%$729,6100.1%
49TTE Totalenergies Se10,723—$729,4860.1%
50LXEO Lexeo Therapeutics Inc155,000−24.4%$722,3000.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.